GGrantIndex
Sort

24,576 grants matching microbiome

Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men

$1,418,675
Anne Frey Luetkemeyer · University Of California, San Francisco · R01 · FY2019 · AI

RP3: Targeting ATG gene-dependent immunity for novel anti-infective therapeutics

$1,418,421
Seungmin Hwang · Ut Southwestern Medical Center · U19 · FY2020 · AI

Biomarkers of Atopy Beginning Early (BABE)

$1,418,167
Kirsi Jarvinen-Seppo · University Of Rochester · U19 · FY2024 · AI

Early Life Exposures and Child Trajectories: Growth and Respiratory Health

$1,417,367
Joseph B Stanford · University Of Utah · UG3 · FY2016 · OD

Long Term Follow up of the Lung Transplant Outcomes Group Cohort

$1,416,878
Jason D Christie · University Of Pennsylvania · U01 · FY2024 · HL

The Impact of the Intrauterine and Early Childhood Environments on Neurocognitive and Metabolic Development in African American Youth: Focus on the Gut-Brain Axis

$1,414,931
Anne Lang Dunlop · Emory University · UG3 · FY2016 · OD

ECHO Renewal for the CANOE Study Cohort

$1,414,688
Tina V Hartert · Vanderbilt University Medical Center · UG3 · FY2024 · OD

Interactions Between the Microbiome, Immunity and Respiratory Health in Traditional Agrarian and Suburban children

$1,413,352
James E. Gern · University Of Wisconsin-Madison · U19 · FY2025 · AI

Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men

$1,412,385
Anne Frey Luetkemeyer · University Of California, San Francisco · R01 · FY2023 · AI

Intestinal bacterial metagenome in pediatric NAFLD

$1,412,109
Nita H Salzman · Medical College Of Wisconsin · R01 · FY2013 · DK

Interventions to improve alcohol-related comorbidities along the gut-brain axis in persons with HIV infection

$1,411,489
Robert L Cook · University Of Florida · P01 · FY2021 · AA

Epidemiologic studies of maternal and early life metabolic risk

$1,409,793
Madhumita Sinha · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

Severe Enteric Disease: Pathogenesis and Response

$1,409,507
James B Kaper · University Of Maryland Baltimore · U19 · FY2012 · AI

Clinical Research on Nonalcoholic Fatty Liver Disease

$1,408,077
Rohit Loomba · University Of California, San Diego · U01 · FY2020 · DK

Interactions Between the Microbiome, Immunity and Respiratory Health in Traditional Agrarian and Suburban children

$1,407,863
James E. Gern · University Of Wisconsin-Madison · U19 · FY2024 · AI

Examining Gut Microbiome as a Determinant of Blueberry Polyphenol Bioavailability to Optimize Dose and Phytochemical Standardization for Functional Effects in Humans

$1,407,811
Tiffany L Weir · Colorado State University · RM1 · FY2025 · AT

Technology Core

$1,407,441
Mark D Adams · J. Craig Venter Institute, Inc. · U19 · FY2014 · AI

Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases

$1,407,242
Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIH · FY2019 · AR

Genomic Analyses for Elucidating Novel Targets for Symptoms Management

$1,407,203
Ann Cashion · National Institute Of Nursing Research · ZIA · FY2018 · NR

Biostatistics for Research in Environmental Health

$1,406,501
Rebecca Fry · Univ Of North Carolina Chapel Hill · T32 · FY2017 · ES

Center for Health Equity Research (CHER)

$1,405,650
Martha L Daviglus · University Of Illinois At Chicago · U54 · FY2020 · MD

Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (META HIV CVD)

$1,405,622
Matthew S Freiberg · Vanderbilt University Medical Center · P01 · FY2022 · AA

DartCF: The Dartmouth Cystic Fibrosis Research Center

$1,405,453
Dean R Madden · Dartmouth College · P30 · FY2022 · DK

Long Term Follow up of the Lung Transplant Outcomes Group Cohort

$1,404,544
Jason D Christie · University Of Pennsylvania · U01 · FY2022 · HL

MsFLASH: Living a Healthy Menopause

$1,400,000
Katherine Adams Guthrie · Fred Hutchinson Cancer Research Center · R01 · FY2017 · AG